Kronox Lab Sciences Q2 FY26 results: revenue dips, PAT edges up

Revenue DeclineResults View source PDF Explain this filing

KRONOX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹150.00

prior close

₹149.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%-2.9% vs market

Specialty Chemicals peers, median of 85sector+0.7%-2.7% vs sector

On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250 and 2.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-1.3

15m

-1.1

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9+0.9-2.9+0.7-2.7

Next day

-0.6+0.8-1.4+0.4-1.0

-0.7+0.7-1.4+0.5-1.1

-1.3+1.3-2.6-0.1-1.2

-2.6+0.5-3.1-0.8-1.8

-3.6+0.4-3.9-1.8-1.7

-5.2-1.5-3.7-2.3-2.9

15d

-8.6-2.4-6.2-4.1-4.6

-4.0-4.4+0.4-5.2+1.2

-12.2-7.2-5.0-8.9-3.3

-15.9-5.0-10.9-8.6-7.3

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kronox Lab Sciences reported Q2 FY26 standalone unaudited results. Revenue from operations fell about 2.3 percent YoY to roughly 2,429 lakhs from 2,486 lakhs. H1 FY26 revenue was nearly flat at 4,982 lakhs versus 5,005 lakhs. Profit after tax for Q2 rose to around 628 lakhs from 565 lakhs last year. H1 FY26 PAT grew about 3.5 percent to 1,307 lakhs. H1 EPS came in at Rs 3.54 versus Rs 3.42. Auditor Mahesh Udhwani and Associates issued an unmodified review report. The company operates a single segment in high purity specialty fine chemicals. A 5 percent final dividend for FY25 was paid in September 2025.

Likely market impact

Mild revenue softness in Q2 partly offset by steady PAT growth. Clean auditor review and ongoing dividend payout suggest stability for shareholders.